|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Less: Loss from discontinued operations | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile net loss from continuing operations to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Revaluation of warrant liability | |||||
| Deferred income taxes | |||||
| Non-cash in-kind services | |||||
| Loss on forward contract liability | |||||
| Equity in net loss of affiliates | |||||
| Revaluation of financial instruments | |||||
| Revaluation of contingent stock consideration | |||||
| Inventory write-downs | |||||
| Impairment expense | |||||
| Inducement expense | |||||
| Non-cash interest expense | |||||
| Loss on supplier deposits | |||||
| Gain on divestiture of affiliate | |||||
| Loss on debt extinguishment | |||||
| Net losses on asset sales and disposals | |||||
| Other non-cash activity | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Long-term deposits | |||||
| Other assets | |||||
| Accounts payable, accrued expenses and other current liabilities | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases and deposits for property, plant and equipment | |||||
| Divestiture of affiliates | |||||
| Proceeds from the sale of assets | |||||
| Payments to assignee | |||||
| Investments in affiliates | |||||
| Issuance of senior secured note receivable and prepaid acquisition-related consideration | |||||
| Cash and restricted cash acquired in Romeo Acquisition | |||||
| Settlement of price differentials | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs paid | |||||
| Total proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs paid | |||||
| Business Combination and PIPE financing, net of issuance costs paid | |||||
| Proceeds from issuance of common stock under Equity Distribution Agreements, net of commissions and other fees paid | |||||
| Proceeds from issuance of debt, promissory notes and notes payable, net of issuance costs | |||||
| Proceeds from issuances of convertible debt instruments, net of discount and issuance costs | |||||
| Proceeds from insurance premium financing | |||||
| Proceeds from issuance of shares | |||||
| Private Placement | |||||
| Private Offering | |||||
| Proceeds from the exercise of stock options | |||||
| Proceeds from the exercise of stock warrants, net of issuance costs paid | |||||
| Total proceeds from the exercise of stock warrants, net of issuance costs paid | |||||
| Proceeds from issuance of financing obligations, net of issuance costs | |||||
| Repayment of Senior Convertible Notes | |||||
| Payments on finance lease liabilities and financing obligation | |||||
| Payments on insurance premium financing | |||||
| Payment for Coupon Make-Whole Premiums | |||||
| Repayments of collateralized promissory notes | |||||
| Other financing activities | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | |||||
| Cash and cash equivalents, including restricted cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, including restricted cash and cash equivalents, end of period | |||||
| Cash flows from discontinued operations: | |||||
| Operating activities | |||||
| Investing activities | |||||
| Financing activities | |||||
| Net cash used in discontinued operations | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for interest | |||||
| Cash interest received | |||||
| Supplemental noncash investing and financing activities: | |||||
| Conversion of convertible note | |||||
| Toggle Convertible Notes | |||||
| Senior Convertible Notes | |||||
| 8.25% Convertible Notes | |||||
| April 2023 Toggle Convertible Notes | |||||
| Leased assets obtained in exchange for new finance lease liabilities | |||||
| Toggle Convertible Notes issued for paid in kind interest | |||||
| Purchases of property, plant and equipment included in liabilities | |||||
| Accrued commissions under Equity Distribution Agreement | |||||
| Non-cash prepaid in-kind services | |||||
| Accrued Business Combination and PIPE transaction costs | |||||
| Net liabilities assumed from VectoIQ | |||||
| Settlement of forward contract liability | |||||
| Embedded derivative asset bifurcated from Convertible Notes | |||||
| Stock option proceeds receivable | |||||
| Accrued PIK interest | |||||
| Reclassification of conversion features embedded in Toggle Convertible Notes to equity | |||||
| Embedded derivative liability bifurcated from convertible notes | |||||
| 8.25% Convertible Notes | |||||
| April 2023 Toggle Convertible Notes | |||||
| Contingent stock consideration for divestiture of affiliate | |||||
| Reclassification from liability to equity for certain share-based awards | |||||
| Reclassification from equity to liability for certain share-based awards | |||||
| Net assets acquired in Romeo acquisition | |||||
| Accrued debt and equity issuance costs | |||||
| Total accrued debt and equity issuance costs | |||||
| Common stock issued for commitment shares | |||||
| Common stock issued for investments in affiliates, including common stock with embedded put right | |||||
| Acquired intangible assets included in liabilities | |||||
Loading...